If you were a cancer patient, where would you rather be — the United States or Europe?
LONDON — Frustrated by the lack of legislation implemented to lower soaring drug prices in the United States — a key issue that has elicited outrage across both ends of the political spectrum — the White House recently issued a report suggesting that US drug prices aren’t unreasonable, it’s that developed nations aren’t paying their fair share.
“These practices abroad disproportionately cost U.S. patients and taxpayers because they prevent the United States from undertaking domestic policies to lower drug prices without slowing down the pace at which new and better products enter the market,” the researchers wrote.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
